Trial Profile
A Prospective Randomized Controlled Clinical Trial of Comparing ticagreLor Versus clopidogrEl on mIcrocirculation in Patients With Acute cOronary Syndrome Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- Acronyms PLEIO
- 27 Jan 2020 Results published in the American Heart Journal
- 05 Feb 2018 Status changed from recruiting to completed.
- 05 Dec 2015 New trial record